No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

House E&C Subcommittee on Health Holds Another Hearing on Health Care Affordability

House E&C Subcommittee on Health Holds Another Hearing on Health Care Affordability

The House Committee on Energy and Commerce Subcommittee on Health held another hearing on June 10 in its affordability series to explore more...

Read More
TELCOR POC Device Connectivity Updates -2026 Q1

TELCOR POC Device Connectivity Updates -2026 Q1

Lincoln, NE - June 16, 2026 TELCOR QML® has connectivity for more than 160 device types. Whether you are looking to add new testing on devices...

Read More
TELCOR Brings New Operator Management Capabilities to ADLM 2026

TELCOR Brings New Operator Management Capabilities to ADLM 2026

Lincoln, NE – June 12, 2026 – TELCOR Inc, the industry leader in healthcare software for point of care testing and laboratory revenue cycle...

Read More